Drugs / GW597901X
last change Aug 2004 re-read 3 minutes ago

GW597901X

Developed for
asthma
Investigated by
GlaxoSmithKline

Trials 1

200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00354042 Aug 2004 → ? asthma GlaxoSmithKline Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as GW597901X ClinicalTrials.gov intervention name — accepted as the source's own label NCT00354042 ↗
Route Inhaled “repeat inhaled doses of GW597901X” NCT00354042 ↗